908 Devices (NASDAQ: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, and the United States Forest Service (USFS), an agency of the United States Department of Agriculture (USDA), are collaborating on a research effort to extend the capabilities of the MX908 handheld device for rapid detection of toxic pesticides used in illegal marijuana grows on federal lands.

Drug traffickers plant marijuana in remote areas on U.S. federal lands, mainly in the Pacific Southwest, and use toxic and illegal pesticides to accelerate crop growth. USFS personnel currently have no safe and reliable method to conduct pesticide testing at the site of these illegal marijuana grows. They often must take samples from marijuana plants, soil and crop sprayers to a lab to confirm pesticide use, delaying safe site remediation for weeks and even months. The collaboration between USFS and 908 Devices is intended to expand the capability of the MX908 into this important category of toxic materials.

The MX908 is a handheld, battery-powered mass spectrometry device. Law enforcement, first responders and military personnel around the world use the MX908 to safely detect chemicals, explosives and priority drugs in seconds. Mass spectrometry, used in many labs, is the gold standard in analytical technology for trace identification of compounds.

“We’re pleased to partner with the U.S. Forest Service on this important initiative,” said Dr. Christopher D. Brown, CTO and co-founder, 908 Devices. “Our team is dedicated to providing users with simple devices that provide accurate answers in seconds, enabling them to take safe and appropriate action.”

According to a TODAY show broadcast, advocates estimate that California’s national forests are home to 80-85% of the country’s illegal marijuana grows. Drug traffickers reroute millions of gallons of water for these grows and have caused several large wildfires. Pesticides are used on the crops endangering wildlife, water supplies and people.

About 908 Devices

908 Devices Inc. (NASDAQ: MASS) is democratizing laboratory mass spectrometry with its simple handheld and desktop devices, addressing critical-to-life applications. The Company’s devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the most critical problems in life sciences research, bioprocessing, pharma / biopharma, forensics and adjacent markets. The Company is headquartered in the heart of Boston, where it designs and manufactures innovative products that bring together the power of mass spectrometry, microfluidic separations, software automation and machine learning.

Forward Looking Statements

This press release includes “forward looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “expect,” “plan,” “anticipate,” “estimate,” “intend” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including the risks outlined under “Risk Factors” and elsewhere in the Company’s filings with the Securities and Exchange Commission which are available on the SEC's website at www.sec.gov. Additional information will be made available in the Company’s annual and quarterly reports and other filings that it makes from time to time with the SEC. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104006019/en/